Nishan M. DeSilva

Filings by Nishan M. DeSilva span 3 companies, the busiest being Ligand Pharmaceuticals Inc, Cartesian Therapeutics, Inc. and Allos Therapeutics Inc. Between 13 December 2011 and 2 January 2026, the trades on record add up to 22 filings.

Both buying and selling appear: 2 purchases worth €21k, against 6 sales worth €5.2M. Sales outweigh purchases by €5.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 8 share grants and 5 option exercises.

On 6 January 2026 came the latest disclosure, a share grant in Cartesian Therapeutics, Inc. The last insider purchase was made public on 6 December 2021, 1,783 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.